PRMT5 as a druggable target for glioblastoma therapy

BACKGROUND: In spite of standard multimodal therapy consisting of surgical resection followed by radiation and concurrent chemotherapy, prognosis for glioblastoma (GBM) patients remains poor. The identification of both differentiated and undifferentiated “stem cell like” populations in the tumor hig...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Banasavadi-Siddegowda, Yeshavanth Kumar, Welker, Alessandra M, An, Min, Yang, Xiaozhi, Zhou, Wei, Shi, Guqin, Imitola, Jaime, Li, Chenglong, Hsu, Sigmund, Wang, Jiang, Phelps, Mitch, Zhang, Jianying, Beattie, Christine E, Baiocchi, Robert, Kaur, Balveen
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Basic and Translational Investigations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961180/
https://ncbi.nlm.nih.gov/pubmed/29106602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox206
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares